RecruitingNot ApplicableNCT00483249

Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm


Sponsor

Warren J. Gasper, MD

Enrollment

250 participants

Start Date

May 1, 2005

Study Type

INTERVENTIONAL

Conditions

Summary

This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Endovascular Branched Stent-Graft for people with paravisceral abdominal aortic aneurysm and thoracoabdominal aortic aneurysm. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEndovascular Branched Stent-Graft

Industry manufactured branched stent-graft for treatment of TAAA/PVAAA.


Locations(2)

Division of Vascular Surgery, SFVAMC

San Francisco, California, United States

Division of Vascular Surgery, UCSF

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00483249


Related Trials